Advertisement
COO vs ICUI
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COO is a StrongBuy and ICUI is a Buy.
COO's RSI Oscillator recovers from oversold territory
The RSI Indicator for COO moved out of oversold territory on October 09, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 36 similar instances when the indicator left oversold territory. In 26 of the 36 cases the stock moved higher. This puts the odds of a move higher at 72%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 16, 2026. You may want to consider a long position or call options on COO as a result. In 55 of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 61%.
The Moving Average Convergence Divergence (MACD) for COO just turned positive on September 25, 2026. Looking at past instances where COO's MACD turned positive, the stock continued to rise in 25 of 42 cases over the following month. The odds of a continued upward trend are 60%.
Following a +1.32% 3-day Advance, the price is estimated to grow further. Considering data from situations where COO advanced for three days, in 153 of 272 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where COO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.
The Aroon Indicator for COO entered a downward trend on September 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. COO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 58 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.350) is normal, around the industry mean (4.887). P/E Ratio (20.177) is within average values for comparable stocks, (35.995). Projected Growth (PEG Ratio) (0.532) is also within normal values, averaging (4.456). Dividend Yield (0.001) settles around the average of (0.006) among similar stocks. P/S Ratio (2.526) is also within normal values, averaging (56.074).
The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is 80 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 86 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. COO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
ICUI's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for ICUI turned positive on September 24, 2026. Looking at past instances where ICUI's MACD turned positive, the stock continued to rise in 39 of 51 cases over the following month. The odds of a continued upward trend are 76%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ICUI's RSI Indicator exited the oversold zone, 21 of 32 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 66%.
Following a +4.28% 3-day Advance, the price is estimated to grow further. Considering data from situations where ICUI advanced for three days, in 193 of 282 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.
The Aroon Indicator entered an Uptrend today. In 157 of 208 cases where ICUI Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 75%.
Bearish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
The Momentum Indicator moved below the 0 level on October 19, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ICUI as a result. In 68 of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 73%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ICUI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 71%.
ICUI broke above its upper Bollinger Band on October 15, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. ICUI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 86 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.872) is normal, around the industry mean (4.887). ICUI has a moderately high P/E Ratio (134.233) as compared to the industry average of (35.995). Projected Growth (PEG Ratio) (0.081) is also within normal values, averaging (4.456). Dividend Yield (0.000) settles around the average of (0.006) among similar stocks. P/S Ratio (1.808) is also within normal values, averaging (56.074).
The Tickeron SMR rating for this company is 89 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 96 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ICUI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
COO | ICUI | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 30 | 11 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 58 Fair valued | 86 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 80 | 89 | |
PRICE GROWTH RATING 1..100 | 50 | 50 | |
P/E GROWTH RATING 1..100 | 86 | 96 | |
SEASONALITY SCORE 1..100 | 75 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
COO's Valuation (58) in the Medical Specialties industry is in the same range as ICUI (86). This means that COO’s stock grew similarly to ICUI’s over the last 12 months.
COO's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as ICUI (100). This means that COO’s stock grew similarly to ICUI’s over the last 12 months.
COO's SMR Rating (80) in the Medical Specialties industry is in the same range as ICUI (89). This means that COO’s stock grew similarly to ICUI’s over the last 12 months.
COO's Price Growth Rating (50) in the Medical Specialties industry is in the same range as ICUI (50). This means that COO’s stock grew similarly to ICUI’s over the last 12 months.
COO's P/E Growth Rating (86) in the Medical Specialties industry is in the same range as ICUI (96). This means that COO’s stock grew similarly to ICUI’s over the last 12 months.
| COO | ICUI | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 72% | 2 days ago 66% |
| Stochastic ODDS (%) | 2 days ago 61% | 2 days ago 68% |
| Momentum ODDS (%) | 2 days ago 61% | 2 days ago 73% |
| MACD ODDS (%) | 2 days ago 60% | 2 days ago 76% |
| TrendWeek ODDS (%) | 2 days ago 55% | 2 days ago 69% |
| TrendMonth ODDS (%) | 2 days ago 52% | 2 days ago 72% |
| Advances ODDS (%) | 2 days ago 56% | 9 days ago 68% |
| Declines ODDS (%) | 13 days ago 60% | 2 days ago 71% |
| BollingerBands ODDS (%) | N/A | 2 days ago 74% |
| Aroon ODDS (%) | 2 days ago 60% | 2 days ago 75% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
COO’s FA Score shows that 0 FA rating(s) are green while ICUI’s FA Score has 0 green FA rating(s).
- COO’s FA Score: 0 green, 5 red.
- ICUI’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
COO’s TA Score shows that 4 TA indicator(s) are bullish while ICUI’s TA Score has 4 bullish TA indicator(s).
- COO’s TA Score: 4 bullish, 3 bearish.
- ICUI’s TA Score: 4 bullish, 4 bearish.
Price Growth
COO (@Pharmaceuticals: Other) experienced а +8.30% price change this week, while ICUI (@Pharmaceuticals: Other) price change was -1.32% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.77%. For the same industry, the average monthly price growth was -2.59%, and the average quarterly price growth was +7.55%.
Reported Earning Dates
COO is expected to report earnings on Dec 03, 2026.
ICUI is expected to report earnings on Nov 09, 2026.
Industries' Descriptions
@Pharmaceuticals: Other (+0.77% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
Advertisement
What Role Does Inflation Play in my Retirement Planning?
Can you provide an overview of the major stock exchanges in India?
Harnessing the Power of Hydrogen: Analyzing the Best Stocks in the Market
Week (March 17 - 21) in Review: Financial Leaders
Father's Day Sale — up to 75% Off - Faster AI. Superior Results. 50-75% Off for a Limited Time.
COO and
Correlation & Price change
A.I.dvisor indicates that over the last year, COO has been loosely correlated with A. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if COO jumps, then A could also see price increases.
ICUI and
Correlation & Price change
A.I.dvisor indicates that over the last year, ICUI has been loosely correlated with CLPT. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if ICUI jumps, then CLPT could also see price increases.
| Ticker / NAME | Correlation To ICUI | 1D Price Change % | ||
|---|---|---|---|---|
| ICUI | 100% | -0.10% | ||
| CLPT - ICUI | 57% Loosely correlated | +3.05% | ||
| ALGN - ICUI | 50% Loosely correlated | +1.00% | ||
| MMSI - ICUI | 50% Loosely correlated | +1.36% | ||
| A - ICUI | 50% Loosely correlated | +1.83% | ||
| BLCO - ICUI | 49% Loosely correlated | +1.93% | ||
More | ||||